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Abstract
Background: The World Health Organization (WHO) recommends that the role of pharmacists in low-income
settings be expanded to address the increasing complexity of HIV antiretroviral (ARV) and co-infection drug
regimens. However, in many such settings including in India, many pharmacists and pharmacy workers are often
neither well trained nor aware of the intricacies of HIV treatment. The aims of our study were; to determine the
availability of ARVs, provision of ARVs, knowledge about ARVs, attitudes towards HIV-infected persons and self-
perceived need for training among community-based pharmacies in an urban area of India.
Methods: We performed a survey of randomly selected, community-based pharmacies located in Pune, India, in
2004-2005 to determine the availability of ARVs at these pharmacies, how they were providing ARVs and their self-
perceived need for training. We also assessed knowledge, attitudes and perceptions on HIV and ARVs and factors
associated with stocking ARVs.
Results: Of 207 pharmacies included in the survey, 200 (96.6%) were single, private establishments. Seventy-three
(35.3%) pharmacies stocked ARVs and 38 (18.4%) ordered ARVs upon request. The reported median number of ARV
pills that patients bought at one time was 30, a two week supply of ARVs (range: 3-240 pills). Six (2.9%) pharmacy
respondents reported selling non-allopathic medicines (i.e. Ayurvedic, homeopathy) for HIV. Ninety (44.2%)
pharmacy respondents knew that ARVs cannot cure HIV, with those stocking ARVs being more likely to respond
correctly (60.3% vs. 34.8%, p = 0.001). Respondents of pharmacies which stocked ARVs were also more likely to
believe it was a professional obligation to provide medications to HIV-infected persons (91.8% vs. 78.8%, p = 0.007)
but they were also more likely to believe that HIV-infected persons are unable to adhere to their medicines (79.5%
vs. 40.9%, p < 0.01). Knowledge of the most common side effects of nevirapine, abnormal liver enzyme profile and
skin rash, was reported correctly by 8 (3.9%) and 23 (11.1%) respondents, respectively. Seven (3.4%) respondents
reported that they had received special training on HIV, 3 (1.5%) reported receipt of special training on ART and
167 (80.7%) reported that they believed that pharmacy staff should get special training on ART.
Conclusion: There is a high willingness to participate in HIV management among community-based pharmacies
but there is a tremendous need for training on HIV therapies. Furthermore, stigmatizing attitudes towards HIV-
infected persons persist and interventions to reduce stigma are needed, particularly among those that stock ARVs.
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In HIV management, pharmacists in many high-income
countries play an important role in working with other
health care providers (HCP) to ensure quality care and
treatment, including educating patients about medications,
adherence counseling, and assessing drug-drug interactions
[1,2]. This requires being up-to-date regarding HIV and
antiretroviral therapy (ART). In contrast, in low-income
settings, the role of pharmacists and pharmacies has tradi-
tionally been a point of dispersal of medicines. Many,
including the World Health Organization (WHO), recom-
mend that this role be expanded to address the increasing
complexity of ART and co-infection drug regimens[3].
However, in these settings as in India, many pharmacists
and pharmacy workers are often not well trained, yet
engage in practices that extend beyond medicine dispen-
sing, including providing inadequate advice about medica-
tions and ailments[4-6]. Furthermore, it is common for
individuals in low-income settings to seek the advice of
pharmacists and medicine shops first rather than HCP for
the treatment of common ailments[7-9]. In the context of
HIV/AIDS and TB, such practices are particularly proble-
matic and are likely to contribute to increasing drug resis-
tance and treatment failure in the community[10].
India has an estimated 2.5 million persons living with
HIV and many are in need of ART[11]. HIV-infected
patients in India can access ART either by self-paying
for their care in the largely unregulated private health
sector or, as of 2004, at select government hospitals
where ART is now being provided for free under the
National AIDS Control Programme[11]. Despite free
ART, some patients continue to access private pharma-
cies for their ART, including second-line antiretroviral
drugs (ARVs) such as protease inhibitors, which remain
largely unavailable in most government programs. In
2005, there were 559,408 registered pharmacies
throughout India, reflecting a pharmacist to population
ratio of 1:1,840, which is better than the average ratio of
1:2,300 reported in high-income countries[12].
We surveyed community-based pharmacies in Pune,
India, a region with a high prevalence of HIV according
to national India HIV surveillance estimates; to deter-
mine the availability of ARVs, provision of ARVs,
knowledge about ARVs, attitudes towards HIV-infected
persons and self-perceived need for training. Such data
are needed to guide the role and needs of pharmacies
and pharmacists in HIV management in low-income
countries such as India.
Methods
Survey sample
The study was approved by the National AIDS Research
Institute (NARI) Ethics Committee and the Johns
Hopkins University Institutional Review Board. A survey
of licensed community-based pharmacies in Pune, India
was conducted between December 2004 and April 2005.
Pune was selected because it is a high HIV prevalent
district (HIV prevalence >1% in antenatal women), has
many providers who have an HIV practice and because
at the time, the Government’s free ARV access program
had not yet been initiated and therefore ART was
accessed privately through community-based pharma-
cies. In order to accomplish this survey, we used a com-
bination of sampling approaches. First, Pune, which
consists of 48 electoral wards, was divided into four geo-
graphic areas (North, South, East, West). One electoral
ward from each of these four areas was randomly
selected. Trained study staff conducted a door-to-door
mapping of each of these four wards to identify all phar-
macies that were currently in business. All pharmacies
identified by this method were approached for interview.
Secondly, a list of 670 licensed pharmacies across Pune
city was obtained from the Pune Chemists and Pharma-
cists Association (PCPA). A random sample of the phar-
macies from this list was also included in the survey.
Seven (11.8%) of 59 pharmacies that were identified
from the ward sampling were already on the sample
selected from the PCPA list and therefore were
excluded, leaving 52 potentially eligible pharmacies from
the ward sampling. Pharmacies were first contacted by
telephone and an appointment was set up for the survey
among those pharmacies that were contactable and will-
ing to participate. The survey was administered by
trained personnel via a face-to-face interview in the
local Marathi language. The survey instrument was
developed in English and translated. The survey was
piloted and minor changes were made to improve the
flow and clarity of the survey. We excluded pharmacies
whose owners/pharmacists refused participation or
whose doors were closed/unavailable for three visits at
three different time points.
Survey Instrument and data collection
We collected information regarding the characteristics
of the pharmacy and pharmacist, as well as respondents’
knowledge and perceptions regarding sexually trans-
mitted infections (STIs), HIV, and ART. The survey also
focused on specific characteristics of ARVs, such as
whether ARVs are stocked, specific ARVs most com-
monly stocked, and the number of prescriptions dis-
pensed by a particular establishment.
HIV- and ART-specific knowledge of the respondent
was assessed through self-assessed ability to name ARVs
as well as the objective confirmation of this ability. A
knowledge-specific section assessed respondents’ ability
to correctly identify the side effects and appropriate
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perceptions and attitudes toward STIs, HIV, and ART
was also completed using 5-point Likert scale. Questions
which gauged respondents’ confidence in dispensing
ARVs, training on HIV, beliefs regarding HIV patients,
professional obligation to provide treatment, and
patient’s responsibility for their illness were included.
(Additional file 1)
Statistical Methods
Double data entry was performed and data were entered
into Microsoft Access. The major outcome variables
considered were 1) whether or not the pharmacy
stocked ARVs and 2) pharmacist’s self-assessed need for
HIV/AIDS training. The independent variables exam-
ined in relation to both outcomes were whether or not
the respondent could name ARVs correctly, and the
knowledge and attitude/perceptions scores. Other inde-
pendent variables such as the size of the establishment,
the presence of an air conditioner, and the number of
years in business were also considered.
Size of the pharmacy was established based upon the
number of prescriptions dispensed per month, with a
small pharmacy being defined as less than 2000 and a
large pharmacy as 2000 or more prescriptions dispensed
per month. Correct naming of ARVs was first verified,
and then a value was assigned to each respondent for
correct number of drugs named. Respondents who cor-
rectly identified at least one ARV were then split into
two groups based on whether they could name at least
three drugs correctly or not. The items in the 5-point
Likert scale were recoded into three categories: ‘dis-
agree’, ‘not sure’, and ‘agree’.
Knowledge scores were calculated using responses to
six HIV-specific knowledge questions from the survey.
Correct answers were given 1 point while incorrect
responses or ‘don’tk n o w ’ were coded as 0. Certain
questions contained multiple parts, and points were
awarded for responses from each part. Ultimately,
assigned scores reflected a total possible range from a
minimum of 0 to a maximum of 19, for all correct
answers. Association of knowledge and attitudes with
‘stocking ARV’ was tested using Pearson’s c
2 test or
Fisher’s exact test when cell size was small (< 5 observa-
tions). Univariate and multivariate analyses were per-
formed using logistic regression models. Odds ratios
(OR) were calculated and the variables with p-value less
than 0.2 in univariate were entered in the multivariate
model to calculate adjusted odds ratios (AOR) and 95%
confidence intervals, except for “correctly named ARV
drugs” as it was highly collinear with “could name ARV
drugs”. Data were analyzed in SPSS 15.0 for Windows,
SPSS Inc. 1989 - 2006.
Results
Characteristics of survey respondents
Of 309 pharmacy establishments approached, 207
(67.0%) consented to participation. Of these 207, 159
(76.8%) were sampled from the PCPA list of 670 phar-
macies and 48 (23.2%) were sampled by approaching
every single pharmacy mapped in the four electoral
wards. The response rate for the ward-sampled pharma-
cies was 92.3% (48/52). The majority of the survey
respondents were the owners of the pharmacy (n = 183,
88.4%). (Table 1) Of 207 pharmacies, 200 (96.6%) were
single, private establishments, 4 (1.9%) were private
pharmacies that were part of a chain, and 3 (1.5%) were
hospital pharmacies (2 were part of the randomly
selected sample from the PCPA list and one was identi-
fied from the door-to-door mapping).
The majority (67.1%) of these pharmacies were small
establishments (dispensing less than 2,000 prescriptions
per month), with a median number of one employee.
For the majority of pharmacies, the highest training of
on-site pharmacists was the diploma in pharmacy and
only 4 (2.3%) had received any post-graduate training.
Seventy-three (35.3%) pharmacies stocked ARVs. The
most commonly stocked ARVs were lamivudine (n = 46,
63.0%), fixed- dose combination of stavudine/lamuvi-
dine/nevirapine (n = 39, 53.4%), and zidovudine (n = 33,
45.2%). An additional 38 (18.3%) pharmacies ordered
ARVs upon request. The reported median number of
ARV tablets or capsules that patients bought from phar-
macies at one time was 30, a two-week supply of ARVs
(range: 3-240 pills). Of 111 respondents from pharma-
cies which either stocked or ordered ARVs upon
request, 28 (25.7%) believedt h a tt h e i rp a t i e n t su s et h e
same prescription to refill ARVs without seeing a HCP.
Additionally, 6 (2.9%) respondents reported that they
sell non-allopathic medicines (i.e. Ayurvedic, homeop-
athy) for HIV.
HIV and ART-related knowledge
Of 207 respondents, 134 (65.1%) were able to name at
least one opportunistic infection (OI) drug correctly,
131 (63.3%) could name at least one ARV correctly
and 5 (2.4%) could name 5 ARV drugs correctly.
(Table 1) Ninety (44.2%) respondents reported know-
ing that ARVs can never completely cure HIV, with
those stocking ARV being more likely to correctly
respond (60.3% vs. 34.8%). (Table 2) Only a small pro-
portion (≤15%) of respondents who stocked ARVs
knew how many ARVs should be in an ideal ART regi-
m e no rt h a ti tw a sn o ts a f et oa d m i n i s t e rA Z Tw i t h
d4T, and only 1.4% of those who stocked ARVs were
aware of efavirenz being a drug not recommended in
early pregnancy.
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cannot afford to take two tablets of a drug like ‘Triomune’
(fixed-dosed combination of stavudine/lamuvidine/nevira-
pine) a day, 72 (34.8%) answered that they would recom-
mend speaking to a doctor right away. Knowledge of the
two most common side effects of nevirapine, an abnormal
liver enzyme profile and skin rash, were correctly reported
by 8 (3.9%) and 23 (11.1%) respondents, respectively.
Attitudes and perceptions
Fifty-four (26.1%) respondents felt that pharmacists or
others in their establishment had a role in how patients
take ARVs. Forty-six (22.2%) stated that they or others
in their establishment had actually been asked by
patients for advice on how to take ARVs, and 44
( 2 1 . 3 % )r e p o r t e dt h a tt h e yg i v ea d v i c et op a t i e n t sa b o u t
taking ARV drugs. When asked to rate statements
regarding their attitudes towards HIV patients, 171
(82.6%) respondents felt it was a professional obligation
to provide medications to persons with HIV/AIDS and
197 (95.2%) reported that they did not worry about HIV
exposure when dispensing medications to an HIV
patient. Furthermore, 110 (53.1%) reported that patients
with STIs/HIV have looser sexual morals, and 112
Table 1 Characteristics of Pharmacy Survey Respondents in Pune, India*
Characteristic N( % )
Private Single Establishment 200 (96.6)
Position of respondent
Owner 183 (88.4)
Employee 24 (11.6)
Utilities that are present on site
Refrigerator 207 (100.0)
Air Conditioner 26 (12.6)
Computer 96 (46.4)
Internet Access 20 (9.7)
Back-up Generator 74 (35.7)
Median number of prescriptions filled per month (IQR) 1500 (600, 2400)
Size of pharmacy
Small (< 2000 prescriptions filled/month) 139 (67.1)
Large (≥2000 prescriptions filled/month) 68 (32.9)
Pharmacist on site 205 (99.0)
Years in business
< 5 years 57 (27.5)
5 - 15 years 93 (45.0)
> 15 years 57 (27.5)
Verification of authenticity of prescription
Never 10 (4.8)
Sometimes 37 (17.9)
Always 157 (75.8)
Highest training of pharmacists at establishment (N = 175)
Diploma 147 (84.0)
Bachelors Degree 24 (13.7)
Post-graduate Degree 4 (2.3)
Pharmacies that sell non-allopathic medicine for HIV 6 (2.9)
Pharmacies that stock ARV 73 (35.3)
Pharmacies that order upon request but do not stock 38 (18.4)
Median number of ARV prescriptions filled per month (range) 2 (0, 100)
Respondent could name at least one OI drug correctly (N = 206) 134 (65.1)
Respondents who said they could name ARV drugs 134 (64.7)
Pharmacists could actually name ARV drugs
At least one drug 131 (63.3)
At least three drugs 55 (26.6)
Five drugs 5 (2.4)
*N = 207 unless otherwise specified
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Respondents of pharmacies which stocked ARVs were
more likely than those of pharmacies which did not
stock ARVs to feel it was a professional obligation to
provide medications to persons with HIV/AIDS (91.8%
vs. 78.8%) but they were also more likely to feel that
HIV patients are unable to adhere to ARVs (79.5% vs.
40.9%). (Table 3)
Factors associated with ARV stocking and need for HIV
training
Stocking of ARVs was associated with large pharmacy
size, air conditioning, and respondents being able to
name at least 3 ARVs. (Table 4)
In terms of HIV training, 7 (3.4%) respondents
reported that they have received special training on
HIV, 3 (1.5%) reported that they had received special
training on ART specifically and 167 (80.7%) reported
that they believed that people who work in pharmacies
should get special training on ART. There was a trend
that respondents with higher knowledge scores were
more likely to think that pharmacy workers need ARV-
specific training compared to those with low knowledge
scores (adjusted OR 16.3, 95% CI 0.94-281.9, p = 0.055).
(Table 5)
Discussion
Our study, based on a random sample of community-
based pharmacies in an urban high HIV prevalence
region of India, has several important findings. First,
35% of surveyed pharmacies stocked ARVs and an addi-
tional 18% ordered them upon individual requests,
showing that at the time of our survey the treatment
was relatively widely available in community-based phar-
macies. Second, we identified a lack of adequate knowl-
edge regarding HIV and ART among pharmacists,
including among those who stocked ARVs. While not
being able to list ARV names and side effects may have
been expected amongst those respondents whose phar-
macy did not stock ARVs, less than one-third knew that
ARVs can never completely cure HIV. Furthermore,
only 6% respondents were aware that it is inappropriate
to administer AZT with d4T and only 1% knew that efa-
virenz was not recommended during pregnancy. This
lack of awareness raises concern about the qualification
and ability of the respondents to distribute ARVs, parti-
cularly if this distribution is linked with advice given to
the patient. We therefore identified significant knowl-
edge gaps and need for targeted training for pharmacies,
particularly those dispensing ARVs in the community.
Encouragingly, we found in a majority of pharmacy
respondents a sense of professional obligation to provide
medication to persons with HIV/AIDS. In addition, 95%
reported that they did not worry about HIV exposure
when dispensing medications to an HIV-infected person.
Therefore, there appears to be a willingness to care for
and provide ARVs to HIV-infected persons. Neverthe-
less, stigma towards HIV patients remains high with
nearly two thirds of respondents believing that patients
are responsible for their illness and 54% reporting that
HIV patients have looser sexual morals and cannot
adhere to ARV regimens. Such provider-based stigma
can be a significant barrier to health care seeking and
treatment for HIV-infected patients, and is associated
Table 2 Responses to Knowledge Questions by ARV stocking status among 207 Survey Respondents in Pune, India
Question ("Correct answer”) Response Stock
ARV
(n = 73)
Do not stock
ARV
(n = 132)
p-
value*
Minimum number of different drugs that should be included in an ideal antiretroviral
treatment regimen ("3”)
Correct 11 (15.1) 15 (11.4) 0.007
Incorrect 46 (63.0) 59 (44.7)
Don’t
know
16 (21.9) 58 (43.9)
Antiretroviral drugs can completely cure HIV ("Never”) Correct 44 (60.3) 46 (34.8) 0.001
Incorrect 12 (16.4) 22 (16.7)
Don’t
know
17 (23.3) 64 (48.5)
It is safe to administer AZT with d4T ("False”) Correct 8 (11.0) 4 (3.0) 0.016
Incorrect 4 (5.5) 2 (1.5)
Don’t
know
61 (83.6) 126 (95.5)
Drug not recommended in pregnancy ("Efavirenz”) Correct 1 (1.4) 1 (0.8) 0.296
Incorrect 8 (11.0) 7 (5.3)
Don’t
know
64 (87.7) 124 (93.9)
*Association of ‘Stocking ARV’ with knowledge and attitude was tested by Pearson’s c
2 test or Fisher’s exact test when cell sizes were less than 5.
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Therefore, there is continued need to combat stigmatiz-
ing attitudes of pharmacists and other HCP towards
persons living with HIV/AIDS.
Despite the fact that only 26% of those surveyed felt
that pharmacy staff play a role in how patients take ARV
drugs, a majority (81%) felt pharmacy employees should
receive specific training on HIV treatment. Only 3% of
respondents stated they had ever received training on
HIV and only 1% had training on ARV drugs specifically.
As has been seen with pharmacists treating tuberculosis,
there is a willingness to provide treatment and advice to
patients despite not having formal training[10]. Training
for pharmacists in India is needed to increase knowledge
of safe practices and regimens, including drug names,
side effects, and dosages, but also to dispel certain cul-
tural notions that lead to stigma amongst treatment pro-
viders. The administration of an educational or training
intervention would likely be best achieved through an
alliance between the public and private sectors, as private
providers have been shown to not follow the regulations
put in place by the public sphere alone[4,16]. However
whether incentives or mandatory regulation would be
optimal to implement an effective training intervention
needs to be investigated[4].
It appears to be common practice for pharmacists in
India to sell loose medications and partial prescriptions
[9]. In our study, we found 65% of respondents of phar-
macies which stock ARVs have sold 10 or less ARV
tablets or capsules to a patient at one time. While this is
often done to accommodate the patient’s financial ability
to pay for drug, with HIV, such practices can be poten-
tially dangerous and lead to unanticipated treatment
interruptions and increase the risk of drug resistance,
treatment failure and disease progression. Furthermore,
25% of respondents felt that some patients may be using
the same prescription and not visiting their doctor regu-
larly. Therefore, there is a need and opportunity for the
pharmacy to serve as a check point to ensure that
patients are receiving appropriate prescriptions, instruc-
tions about drug safety, and regular treatment from
registered HCP. They should dispense drugs only after
receiving a valid prescriptio nw r i t t e nb ya na u t h o r i z e d
physician. In addition, pharmacies can also serve as
important checkpoints for medication adherence as
pharmacy records of drug dispensing have been used
effectively for estimating adherence to ART[17]. In
high-income settings, almost all pharmacies have com-
puterized databases, which greatly facilitate patient pre-
scription tracking, appropriate drug combinations, and
adherence monitoring[18]. While only 46% respondents
reported having a computer on site and only 10%
reported having internet access, the use of computers
and internet is spreading rapidly in India. Therefore
strategies using computerized pharmacy databases
should be explored and incentivized in India, as these
are likely to yield great benefits over time.
Our study had a few limitations. We likely had some
degree of social desirability bias, which may have
impacted responses related to pharmacy practices, such
as the verification of prescriptions. Use of mock clients,
who present symptoms and requests to pharmacists who
Table 3 Respondent Attitudes towards HIV Patients by ARV stocking status*
Statement Response Stock
ARVs
(n = 73)
Do not stock
ARVs
(n = 132)
p-
value**
“There is a professional obligation to provide medications to persons with HIV/
AIDS”
Disagree 6 (8.2) 12 (9.1) 0.007
Not sure 0 (0) 16 (12.1)
Agree 67 (91.8) 104 (78.8)
“Patients with STIs/HIV are responsible for their illness” (N = 206) Disagree 12 (16.4) 16 (12.2) 0.184
Not sure 12 (16.4) 36 (27.5)
Agree 49 (67.1) 79 (60.3)
“Patients with STIs/HIV have looser sexual morals” Disagree 6 (8.2) 23 (17.4) 0.079
Not sure 21 (28.8) 45 (34.1)
Agree 46 (63.0) 64 (48.5)
“HIV patients cannot adhere to antiretroviral (ARV) regimens” Disagree 10 (13.7) 8 (6.1) < 0.01
Not sure 5 (6.8) 70 (53.0)
Agree 58 (79.5) 54 (40.9)
“Worry about HIV exposure when I dispense medicines to an HIV patient” Disagree 71 (97.3) 124 (93.9) 0.484
Not sure 1 (1.4) 6 (4.5)
Agree 1 (1.4) 2 (1.5)
*N = 207 unless otherwise specified
**Association of ‘Stocking ARV’ with attitudes was tested by Pearson’s c
2 test or Fisher’s exact test when cell sizes were less than 5.
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technique used for future studies[19]. We conducted the
survey in an urban and peri-urban setting in a high HIV
prevalence state of India during a time when less costly
or free ART was not widely available. Therefore, our
results may not necessarily be generalizable to other
regions and settings in India, such as rural areas or states
with lower prevalence, where there may be a decreased
HIV awareness. Furthermore, our survey consisted of lar-
gely small, private pharmacies, so the results may not
directly reflect the situation of very large or public hospi-
tal pharmacies. Nevertheless, the study was conducted on
a sizable population and used a rigorous method of
mapping and random sampling to obtain a representative
sampling of community-based pharmacies in the Pune
area. Since most of the ART scale-up in India since 2004
has occurred in the public government ART pharmacies,
there may have been some changes in private pharmacy
practices, however this would need to be confirmed. By
and large, even with an expansion in the Government
supported ART roll-out program in India since 2004, the
accessibility to ART has not reached beyond 25% of
those in need of ART [11] and some patients continue to
obtain ARVs, including second line ARV drugs, from
pharmacies such as those included in our study. Thus,
our findings have a major relevance even today.
Table 4 Association of Respondent Characteristics with the Stocking of ARV Drugs
Characteristics Total
N* (%)
Stock
ARVs
Do not stock
ARVs
Univariate OR
(95% CI)
p-
value
Multivariate
AOR
(95% CI)
p-
value
Air Conditioner
No 179
(87.3)
59 (80.8) 120 (90.9) referent referent
Yes 26 (12.7) 14 (19.2) 12 (9.1) 2.37 (1.03 -
5.45)
0.042 3.77 (1.03 -
13.89)
0.046
Years in Business
< = 5 years 57 (27.8) 14 (19.2) 43 (32.6) referent referent
> 5 years 148
(72.2)
59 (80.8) 89 (67.4) 2.04 (1.02 -
4.05)
0.043 2.01 (0.83 - 4.90) 0.123
Size of Establishment
Small 137
(66.8)
35 (47.9) 102 (77.3) referent referent
Large 68 (33.2) 38 (52.1) 30 (22.7) 3.69 (2.00 -
6.82)
< 0.01 3.18 (1.39 - 7.24) 0.006
Verification of Prescription Authenticity
# (N=
202)
Never 10 (4.9) 5 (7.0) 5 (3.8) referent
Sometimes 36 (17.8) 11 (15.5) 25 (19.1) 0.44 (0.11 -
1.84)
0.260 –
Always 156
(77.2)
55 (77.5) 101 (77.1) 0.55 (0.15 -
1.96)
0.353
Could Name OI Drugs
No (Incorrect) 79 (38.5) 22 (30.1) 57 (43.2) referent referent
Partially correct 30 (14.6) 12 (16.4) 18 (13.6) 1.73 (0.72 -
4.17)
0.224 0.83 (0.25 - 2.77) 0.762
Yes (Correct) 96 (46.8) 39 (53.4) 57 (43.2) 1.77 (0.94 -
3.36)
0.079 1.50 (0.61 - 3.70) 0.383
Correctly Named ARV Drugs (N = 131)
Less than 3 76 (58.0) 33 (45.8) 43 (72.9) referent referent
More than 3 55 (42.0) 39 (54.2) 16 (27.1) 3.18 (1.52 -
6.64)
0.002 3.54 (1.52 - 8.24) 0.003
Knowledge Score
#
Low 6 (2.9) 2 (2.7) 4 (3.0) referent
Middle 175
(85.4)
56 (76.7) 119 (90.2) 0.94 (0.17 -
5.29)
0.945 –
High 24 (11.7) 15 (20.5) 9 (6.8) 3.33 (0.51 -
22.0)
0.211
*N = 205 unless otherwise specified, # variables not included in multivariate model
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the distribution of treatment in licensed pharmacies
could provide a much needed resource, particularly in
settings where stigma may affect patients’ quality of life
and willingness to access treatment. Such a model has
already been used in India, with the conception of a
pharmacy run by persons living with HIV/AIDS for the
specific provision of ART at a subsidized cost. However
such a model cannot be a solution for every pharmacy
in India, which provides medicines for HIV or co-
infections.
Conclusions
This study emphasizes that approximately half of the
community-based pharmacies surveyed that were based
in a large peri-urban area of India dispense ARVs. How-
ever there was low knowledge about HIV therapies and
stigmatizing attitudes towards HIV-infected patients,
even among those who stocked ARVs. However
encouragingly, there appears to be high willingness to
participate in the provision of care for HIV-infected
persons and a perceived need for focused training on
HIV therapies. Before the role of the pharmacist in
India is extended beyond the traditional task of dispen-
sing medications, further training particularly in phar-
macies that stock or order ARVs is needed[1,20,21].
Pharmacies can serve as an excellent checkpoint for
ensuring appropriate HIV and co-infection therapies but
only if there is appropriate training, knowledge and will-
ingness to serve in this role.
Additional material
Additional file 1: Pharmacy survey questionnaire.
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(32.9)
54 (32.3) 14 (35.0) 0.89 (0.43 - 1.83) 0.747 1.96 (0.75 -
5.13)
0.172
Could Name OI Drugs
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281.9)
0.055
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